FOSUN HEALTH Logo

Atrial Fibrillation & Arrhythmia Overview

catalogue

Atrial Fibrillation & Arrhythmia Overview

Atrial Fibrillation & Arrhythmia Overview

Atrial fibrillation is the commonest sustained arrhythmia: the upper chambers stop contracting in an organised way and the pulse becomes irregular — sometimes racing, sometimes barely noticeable. It matters for two entirely different reasons. The first is what it costs the patient — palpitations, breathlessness, fatigue, a quiet loss of exercise capacity, and in some people nothing at all. The second is what it does to the risk of stroke, which rises whether or not any symptom is ever felt. This guide separates those two threads deliberately, because they are assessed with different tests and answered with different treatments — and because treating the rhythm is not the same act as protecting the brain.

Atrial Fibrillation & Arrhythmia Overview
  • Emergency cardiac cover at both flagship hospitals

  • Specialised cardiovascular beds across the two flagship hospitals

  • National certifications at the Foshan hospital, including its atrial fibrillation centre

  • Countries and regions our international patients come from

What atrial fibrillation is — an electrical problem, not a plumbing problem

Every heartbeat begins as an electrical signal. A small cluster of cells in the upper right chamber, the sinus node, fires on its own; the impulse then spreads across the two upper chambers — the atria — making them contract, and passes down a single narrow gateway to the ventricles, which contract a moment later. That sequence is what produces a pulse you can feel: a small filling beat, then the main one.

In atrial fibrillation the sequence breaks down. Instead of one organised wave, several hundred disorganised impulses circulate around the atria each minute, often beginning at the openings through which the pulmonary veins enter the left atrium. The atria stop contracting usefully and simply quiver. The gateway to the ventricles is then bombarded irregularly, so the ventricles beat at an uneven and often fast pace. On an electrocardiogram the pattern is unmistakable; under a finger on the wrist it produces the irregularly irregular pulse that doctors treat as the physical signature of AF.

Two clarifications belong at the start, because both cause real confusion. First, arrhythmia is an umbrella term rather than one disease: it covers rhythms that begin in the atria and rhythms that begin in the ventricles, and those two families carry very different consequences. Atrial fibrillation is the commonest sustained arrhythmia in adults and belongs to the atrial family — which is why it is frightening to live with while rarely being immediately dangerous, whereas some rhythms from the lower chambers are the reverse. Second, an uneven pulse has more than one possible explanation, and working out which one a patient has is the first job of the assessment rather than an assumption to be made from the pulse alone.

One boundary is worth stating plainly, because patients often arrive carrying it: atrial fibrillation is not the same disease as coronary heart disease, heart failure or valve disease. The coronary arteries, the heart muscle and the valves each have their own guides, because each is investigated and treated differently. They also meet frequently — a leaky mitral valve and a weakened muscle both encourage the rhythm, and the rhythm in turn can weaken the muscle — but "my heart has a problem" has several distinct answers, and this guide is about the electrical one.

The spectrum: how the arrhythmias differ in origin and in duration

The family of arrhythmias is sorted along two independent lines: where the rhythm originates, and how long it persists once it starts. The first line separates rhythms that are uncomfortable from rhythms that are dangerous; the second line describes how much the atrium has already changed, and therefore which treatments remain realistic.

Rhythm What is happening What it usually means
Paroxysmal atrial fibrillation Episodes that begin on their own and stop on their own, usually within a week and often within a day The earliest stage, and the one in which the trigger is easiest to identify — the pulmonary vein openings dominate, so isolating them addresses the mechanism directly
Persistent atrial fibrillation The rhythm does not stop by itself and is still present after a week; it ends with treatment such as cardioversion or an ablation The atrial tissue has begun to remodel, so restoring a normal rhythm is still pursued but the plan is usually larger
Long-standing persistent or permanent atrial fibrillation The rhythm has been continuous for a year or more, or the decision has been made with the patient to stop trying to restore a normal rhythm Rate control and stroke prevention become the backbone; the label records a shared decision, not a failure
Atrial flutter A single electrical circuit circling the right atrium, usually at around 300 impulses a minute, with the ventricles responding to a regular fraction of that Sits alongside AF — the same stroke-risk logic applies, the same anticoagulation conversation follows, and the circuit itself is often highly treatable by ablation
Supraventricular tachycardia A short circuit above the ventricles — most often inside the AV node or along an extra pathway — producing attacks that start and stop abruptly and remain regular Uncomfortable rather than dangerous in most cases; attacks can be stopped by manoeuvres or medicines and cured by a small ablation
Ventricular ectopics and ventricular tachycardia Extra beats, or fast rhythms, arising in the ventricles themselves — the pumping chambers A different family with a different urgency: they are assessed for underlying structural disease, and a sustained ventricular rhythm is an emergency rather than an outpatient question

Two questions run through that table, and keeping them apart prevents most confusion. The first is where the rhythm begins — the atria or the ventricles — because it is the ventricular rhythms that can be immediately life-threatening. The second is how long it lasts, because duration tells you how much the atrial tissue has already changed. Atrial fibrillation is the arrhythmia whose answers move over time: patients drift from paroxysmal to persistent, and a rhythm that has been successfully treated does not always stay treated.

There is also a feedback loop inside the process that shapes everything downstream. An atrium that spends weeks fibrillating loses contractile muscle and gains fibrous tissue, and a stiffer, more fibrous atrium holds on to the rhythm more stubbornly than it did at the start. That is the practical reason clinicians do not simply leave a symptomatic rhythm alone for years, and it is why the label in the table above describes where a patient is now rather than naming a permanent state. The treatments that follow from each label — rate control, rhythm control, ablation, anticoagulation — are compared on the treatment options page.

Two harms that are read separately: what the rhythm costs, and what it risks

Atrial fibrillation is unusual among heart conditions in one respect. How unwell a patient feels, and how dangerous the condition is, are two separate readings taken with different tools. The first is the symptom burden — the cost of the rhythm to daily life: breathlessness on the stairs, a pulse that will not settle at night, a fatigue that has quietly removed the last mile of a walk. That burden is graded rather than guessed at, and the grading exists to make a vague complaint into a concrete conversation; the symptoms page sets out how the grades are described and what each one changes.

The second reading is the risk of stroke, and it has nothing to do with whether anything is felt. When the atria stop contracting as a unit, blood slows and pools in the left atrium — and the place it pools most reliably is a small, blind-ended pouch attached to it, the left atrial appendage. A clot that forms there can leave the heart, travel up the arteries of the neck and lodge in the brain. Most of the clots responsible for strokes in people with atrial fibrillation come from that pouch. The whole process is silent by nature: it does not announce itself with palpitations, and for a substantial number of patients a stroke is the first evidence that the rhythm had ever been abnormal.

Because the two readings are different, they lead to different treatments rather than to one. The symptom reading drives the choice between controlling the rate and restoring a normal rhythm. The stroke reading drives anticoagulation — and that decision is not left to impression. It is structured by a checklist of the factors that raise stroke risk in atrial fibrillation, known by its initials as CHA₂DS₂-VASc, completed for every patient; against it sits a parallel assessment of bleeding risk, because the two are always weighed together. How that assessment runs, and what the letters stand for, belongs to the diagnostic page — and neither score replaces the conversation that follows it.

The third thing assessed is not a score at all but the ground the rhythm is growing in: the size of the atria, the state of the valves, how long the rhythm has been present and how much of the day it occupies. A large, fibrous atrium with a leaking mitral valve and a rhythm continuous for two years is a different starting point from a normal-sized heart whose episodes last an afternoon. That distinction appears in neither score, it is read from the echocardiogram, and it is the honest reason two patients carrying the same diagnosis are offered different plans.

How the assessment is ordered, and why the order matters

The assessment is organised around a single difficulty: atrial fibrillation is intermittent, and a test only finds what happens while it is running. A 24-hour monitor is decisive for a patient whose episodes come most days, and nearly useless for one whose episodes come once a month. That one fact dictates the order of the work — and it is why a normal electrocardiogram in an emergency department does not close the question.

The order matters for a second reason as well. Some rhythms are dangerous within the next hour — a sustained ventricular rhythm, or atrial fibrillation with a very fast rate in a patient who is already unwell — and those are excluded first, before anything elective is planned. Only then does the work turn to characterising the rhythm, describing the heart that carries it, and quantifying the risk it creates.

Establish what the rhythm actually is

A 12-lead electrocardiogram taken during symptoms settles it. If no tracing was captured, a description of what the patient felt is a reason to keep looking, not a diagnosis.

Catch it if it is intermittent

The monitoring window is matched to how often the episodes come — a single day, a week, a fortnight, or a small recorder placed under the skin for months.

Describe the heart that carries it

An echocardiogram answers the questions that change treatment: the size of the atria, the state of the valves, and how well the muscle pumps.

Quantify the risk and settle what is reversible

Stroke-risk factors are recorded with bleeding risk beside them, and the reversible drivers — thyroid, blood pressure, sleep apnoea, alcohol — are identified before a plan is made.

Every test answers one question and none of them answers another's. Which tool answers which question — and what each tool cannot do — is set out one by one on the diagnosis page, together with the four things a completed assessment should be able to state.

Why patients travel to China for rhythm treatment

Rhythm treatment is decided from tracings, images and scores, and all three travel well. The electrocardiograms stored on a phone, the echocardiogram report, the monitor printouts and the list of what has already been tried are enough for a cardiology team to form a view before anyone books a flight. What differs between providers is the span of what can be done once the patient is in the room: whether the electrophysiology laboratory, the emergency service and the surgical backup sit under one roof, and how quickly a visiting patient moves from records to a decision.

Our cardiovascular service runs across two flagship hospitals — Fosun Hospital Foshan and Fosun Hospital Guangzhou — with nearly 170 specialised cardiovascular beds, coronary care units and electrophysiology laboratories, and emergency cover around the clock at both. The Foshan hospital holds five national certifications — chest pain, atrial fibrillation, heart failure, cardiac rehabilitation and hypertension — the first hospital in its city to hold them, and the atrial fibrillation centre among them covers precisely the work described on this page: confirming the rhythm, managing rate and rhythm, catheter ablation and pulmonary vein isolation, anticoagulation, and structured follow-up. The Guangzhou hospital obtained national chest pain centre certification in 2025.

For a patient coming from abroad, records reviewed by a cardiology team receive a written opinion within about 48 hours of complete records arriving. With a rhythm problem the useful records are the tracings themselves — the electrocardiograms, the monitor reports, the dates and the duration of the episodes, and any note of what the pulse was doing during them — rather than a summary line that says only "atrial fibrillation". Complete treatment in China typically runs at 30–50% of comparable care in Europe or the United States, we work with more than 30 commercial insurers for direct billing, and our international patients have come from 124 countries and regions. The follow-up that keeps a rhythm stable — medication review, monitoring, rehabilitation — is delivered on site rather than handed over as a leaflet.

Frequently Asked Questions

Is atrial fibrillation dangerous, or just unpleasant?

Both readings are true, and they are separate. For most patients the rhythm itself is not immediately life-threatening, and many people live with it for years while treatment controls the rate and protects against clots. What makes it serious is the stroke risk that travels with it, which is present whether or not there are symptoms and is the reason anticoagulation is discussed even with someone who feels entirely well. The genuinely urgent situations are different ones: a very fast rate with dizziness, chest pain or breathlessness, fainting, or any sign of a stroke. If those appear, this question stops being academic.

Can atrial fibrillation be cured, or only controlled?

It is controlled more often than cured, and the word cured overstates what ablation does. A pulmonary vein isolation can remove the triggers that start episodes, and a proportion of patients — the highest share among those with paroxysmal AF and a normal-sized heart — stay free of the rhythm afterwards without medication; for others it returns and the procedure is repeated or a drug is added. Even where the rhythm stays normal, the stroke-risk assessment continues, because the risk carried by the patient's other factors does not leave when the rhythm does. The honest expectation is a long-term plan, punctuated by long stretches of normal rhythm.

If I feel nothing at all, does it still need treatment?

Yes, and this is the point patients find most counter-intuitive. Feeling nothing means the rhythm is not costing you much today; it does not mean the risk is low. Stroke risk is calculated from age, blood pressure, diabetes, heart failure, prior stroke and other factors, not from how the rhythm feels — and a patient with no symptoms at all can be the one for whom anticoagulation matters most. Silent atrial fibrillation is also commonly found late, sometimes only after a stroke, which is why a rhythm picked up on a watch or a routine pulse check deserves assessment rather than dismissal.

Is atrial fibrillation the same as heart failure?

No, though they meet often and each makes the other worse. Heart failure is a problem of the muscle's pumping; atrial fibrillation is a problem of the electrical sequence. They are separate conditions, each with its own guide, and a patient can have either one alone. When both are present they are managed as a single problem, because a fast uncontrolled rhythm weakens the muscle and a weak muscle makes the rhythm harder to control. Being told you have both therefore does not mean the two have merged into one disease; it means the plan has to address them together.

Patient Stories

Stories from our atrial fibrillation arrhythmia programme, pulled automatically from the patient story library by disease tag.

View all patient stories →

Send the rhythm strips, and the dates they were recorded

Send us the electrocardiograms themselves — the clinic strips, the photographs of your watch recordings with their dates and times, the monitor reports — together with the echocardiogram and the medication list. A cardiology team will return a written opinion: what the rhythm is, how much of the day it occupies, what the assessment still needs, and which of rate control, rhythm control and anticoagulation applies to you.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*